LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

Search

Quanterix Corp

Închisă

SectorSănătate

6.99 -4.64

Rezumat

Modificarea prețului

24h

Curent

Minim

6.96

Maxim

7.37

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

-18.48% downside

Statistici piață

By TradingEconomics

Capitalizare de piață

115M

353M

Deschiderea anterioară

11.63

Închiderea anterioară

6.99

Sentimentul știrilor

By Acuity

50%

50%

169 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

16 dec. 2025, 23:46 UTC

Market Talk

Gold Edges Higher, Aided by Fed Rate-Cut Prospects -- Market Talk

16 dec. 2025, 23:38 UTC

Market Talk

Nikkei May Rise on Possible Bargain-Hunting Interest -- Market Talk

16 dec. 2025, 22:35 UTC

Achiziții, Fuziuni, Preluări

Santos: Sale Delivered Cash, Reduced Future Decommissioning Exposure

16 dec. 2025, 22:35 UTC

Achiziții, Fuziuni, Preluări

Santos Sold 43% Stake in Petrel Fields, 100% of Tern Fields to Eni Australia

16 dec. 2025, 22:33 UTC

Achiziții, Fuziuni, Preluări

Santos: A$40M Upfront Consideration, Up to A$20M in Contingent Payments

16 dec. 2025, 22:33 UTC

Achiziții, Fuziuni, Preluări

Santos Sold 43% Operated Interest in Mahalo JV to Comet Ridge

16 dec. 2025, 22:32 UTC

Achiziții, Fuziuni, Preluări

Santos Divests Two Noncore Assets as Part of Portfolio Optimization

16 dec. 2025, 22:25 UTC

Achiziții, Fuziuni, Preluări

Westgold's Indicative Timetable Points to Early February Completion

16 dec. 2025, 22:24 UTC

Achiziții, Fuziuni, Preluări

Westgold: Divestment Aligns With Broader Corporate Strategy

16 dec. 2025, 22:23 UTC

Achiziții, Fuziuni, Preluări

Westgold: Deferred Payment Based on Performance Hurdles

16 dec. 2025, 22:23 UTC

Achiziții, Fuziuni, Preluări

Westgold Will Receive A$15M Cash, A$19.6M in Alicanto Shares

16 dec. 2025, 22:23 UTC

Achiziții, Fuziuni, Preluări

Westgold to Receive A$30M Deferred Payment in Cash or Shares

16 dec. 2025, 22:22 UTC

Achiziții, Fuziuni, Preluări

Westgold Divesting Noncore Operating Asset for A$64.6M

16 dec. 2025, 22:22 UTC

Achiziții, Fuziuni, Preluări

Westgold Agrees to Sell Mt Henry-Selene Project to Alicanto Minerals

16 dec. 2025, 21:53 UTC

Câștiguri

Lennar Misses Earnings Estimates. The Stock Is Dropping. -- Barrons.com

16 dec. 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

16 dec. 2025, 21:33 UTC

Achiziții, Fuziuni, Preluări

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- 2nd Update

16 dec. 2025, 21:18 UTC

Achiziții, Fuziuni, Preluări

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- Update

16 dec. 2025, 21:17 UTC

Achiziții, Fuziuni, Preluări

Worthington Enterprises to Buy LSI Group for About $205M >WOR

16 dec. 2025, 21:16 UTC

Câștiguri

Worthington Enterprises 2Q Sales $327.5M >WOR

16 dec. 2025, 21:16 UTC

Câștiguri

Worthington Enterprises 2Q Adj EPS 65c >WOR

16 dec. 2025, 21:16 UTC

Câștiguri

Worthington Enterprises 2Q EPS 55c >WOR

16 dec. 2025, 21:15 UTC

Achiziții, Fuziuni, Preluări

Worthington Enterprises Agrees To Acquire Leading Metal Roof Components Manufacturer LSI Group >WOR

16 dec. 2025, 21:05 UTC

Achiziții, Fuziuni, Preluări

Ecolab Closes Acquisition Of Ovivo's Electronics Ultrapure Water Business >ECL

16 dec. 2025, 20:54 UTC

Achiziții, Fuziuni, Preluări

Warner to Reject Paramount Offer As Soon As Wednesday, Sources Say -- WSJ

16 dec. 2025, 20:54 UTC

Achiziții, Fuziuni, Preluări

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- WSJ

16 dec. 2025, 20:54 UTC

Achiziții, Fuziuni, Preluări

Warner to Recommend Existing Netflix Deal, Sources Say -- WSJ

16 dec. 2025, 20:44 UTC

Market Talk

Russia-Ukraine Peace Efforts Send Crude to Near 5-Year Low -- Market Talk

16 dec. 2025, 20:04 UTC

Market Talk

U.S. Natural Gas Extends Weather-Driven Losing Streak -- Market Talk

16 dec. 2025, 20:01 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

-18.48% jos

Prognoză pe 12 luni

Medie 6 USD  -18.48%

Maxim 7 USD

Minim 5 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

169 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat